Published • loading... • Updated
Alzheimer's among elderly more widespread than previously thought, new study shows
A study using a simple blood test found 11% of people over 70 meet criteria for antibody treatments that can slow early Alzheimer's disease progression.
- Researchers at King's College London analysed 11,486 Trondelag Health Study blood samples and found around 11% of participants over 70 meet eligibility for monoclonal antibody treatments.
- Using a blood biomarker test, researchers found Alzheimer's disease neuropathological changes rise sharply with age, from fewer than 8% in ages 65-69 to 65.2% in those over 90.
- In participants over 70, 10% had pre-clinical Alzheimer's, while ADNC was present in 60 in dementia cases and 32.6 in mild cognitive impairment, the study shows.
- Health services face challenges as lecanemab and donanemab, licensed but excluded by the spending watchdog, carry risks and require NHS preparation for specialist diagnostic tests not yet available.
- More than 130 drugs in development aim to expand Alzheimer’s treatments, but experts advise caution and explore blood-based biomarkers for GP and primary care use.
Insights by Ground AI
7 Articles
7 Articles
Banner Health part of global study that reveals higher Alzheimer’s prevalence than expected
Research that shows blood test analysis with more than 1 in 10 adults over 70 may be eligible for treatments to slow cognitive decline Nicholas Ashton, PhD Headshot for Dr....
·Manila, Philippines
Read Full ArticleAlzheimer's among elderly more widespread than previously thought, new
Alzheimer’s disease is more widespread in people above the age of 85 than previously thought, a pioneering study has suggested. Researchers used a simple blood test to search for biomarkers associated with the development of dementia. The study also found more than one in 10 people over the age of 70 would meet the criteria for drugs that can slow down the early stages of Alzheimer’s. Researchers at King’s College London, University of Gothenbur…
Coverage Details
Total News Sources7
Leaning Left0Leaning Right3Center2Last UpdatedBias Distribution60% Right
Bias Distribution
- 60% of the sources lean Right
60% Right
C 40%
R 60%
Factuality
To view factuality data please Upgrade to Premium





